Please use this identifier to cite or link to this item: http://repositorio.ufc.br/handle/riufc/62483
Type: Artigo de Periódico
Title: Linking Zinc and Leptin in Chronic Kidney Disease: Future Directions
Authors: Lobo, Julie Calixto
Aranha, Luciana Nicolau
Moraes, Cristiane
Brito, Luciana Catunda
Mafra, Denise
Keywords: Leptin;Zinc;Anorexia;Chronic kidney disease
Issue Date: 2011
Publisher: Biological Trace Element Research
Citation: LOBO, Julie Calixto et al. Linking Zinc and Leptin in Chronic Kidney Disease: Future Directions. Biological Trace Element Research, [s. l.], v. 146, n. 1, p. 1-5, 2011.
Abstract in Brazilian Portuguese: Anorexia is a common complication in patients with chronic kidney disease (CKD) and is associated with the development of malnutrition and an increased risk of mortality. Several compounds are linked to anorexia in these patients; however, the mechanisms are unknown. Zinc (Zn) deficiency is associated with decreased food intake and has been observed in CKD patients. In addition, leptin is an anorexigenic peptide, and patients with CKD present generally high levels of this hormone. Studies have suggested an association between Zn and leptin status in human and rats; however, the results are inconsistent. Some claimed that Zn supplementation does not change leptin release or that there is no significant relationship between Zn and leptin. Others have reported that Zn might be a mediator of leptin production. CKD patients have hyperleptinemia and hypozincemia, but the relationship between Zn deficiency and leptin levels in CKD patients has been poorly understood until now. The aim of this review is to integrate knowledge on leptin and Zn actions to provide a cohesive clinical perspective regarding their interactions in CKD patients
URI: http://www.repositorio.ufc.br/handle/riufc/62483
Appears in Collections:IEFES - Artigos publicados em revistas científicas

Files in This Item:
File Description SizeFormat 
2011_art_jclobo.pdf122,1 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.